Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany
出版年份 2023 全文链接
标题
Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 22, Issue 1, Pages 921-932
出版商
Informa UK Limited
发表日期
2023-10-26
DOI
10.1080/14760584.2023.2262575
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?
- (2023) Eileen M. Dunne et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time
- (2022) Ralf Sprenger et al. PLoS One
- Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination
- (2022) Antonia Morga et al. VACCINE
- 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae
- (2022) Thomas Chandler et al. Microorganisms
- Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine
- (2022) Amber Hsiao et al. JAMA Network Open
- Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses
- (2022) Leela R. L. Davies et al. Science Translational Medicine
- Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly
- (2022) Shu-ling Hoshi et al. VACCINE
- Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease
- (2022) Diana Mendes et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in Denmark compared with PPV23
- (2022) Jens Olsen et al. JOURNAL OF MEDICAL ECONOMICS
- The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia
- (2021) Bradford D. Gessner et al. Expert Review of Vaccines
- Higher-Valency Pneumococcal Conjugate Vaccines: An Exploratory Cost-Effectiveness Analysis in U.S. Seniors
- (2021) Kenneth J. Smith et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Pneumokokkenimpfstoffe
- (2021) Mathias W. Pletz et al. INTERNIST
- Effectiveness of Pneumococcal Vaccination Against Hospitalized Pneumococcal Pneumonia in Older Adults: A Prospective, Test-Negative Study
- (2021) Jung Yeon Heo et al. JOURNAL OF INFECTIOUS DISEASES
- Population-based incidence and mortality of community-acquired pneumonia in Germany
- (2021) Christian Theilacker et al. PLoS One
- Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH)
- (2021) Joon-Young Song et al. VACCINE
- Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
- (2021) Lerato Mohapi et al. AIDS
- Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Medically Attended Lower Respiratory Tract Infection and Pneumonia Among Older Adults
- (2021) Joseph A Lewnard et al. CLINICAL INFECTIOUS DISEASES
- Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years
- (2021) Brandon Essink et al. CLINICAL INFECTIOUS DISEASES
- Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age
- (2020) Donald Hurley et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study
- (2020) Hannah Lawrence et al. PLOS MEDICINE
- Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study
- (2019) Jong Hun Kim et al. VACCINE
- Limited indirect effects of an infant pneumococcal vaccination program in an aging population
- (2019) Mark van der Linden et al. PLoS One
- Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design
- (2018) John M McLaughlin et al. CLINICAL INFECTIOUS DISEASES
- Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
- (2018) Shamez N Ladhani et al. LANCET INFECTIOUS DISEASES
- Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany
- (2018) Ulrike Kuchenbecker et al. PLoS One
- Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles
- (2018) Nicholas J. Croucher et al. Annual Review of Microbiology
- Pneumococcal vaccination patterns among persons aged 65 years or older in the United States: A retrospective database analysis
- (2018) Xiaoqin Yang et al. VACCINE
- Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination
- (2017) G. L. Masala et al. Journal of the Royal Society Interface
- Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study
- (2017) Motoi Suzuki et al. LANCET INFECTIOUS DISEASES
- Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years
- (2017) Carla L. Black et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease
- (2017) Rebecca Bornheimer et al. PLoS One
- Serotype-specific differences in short- and longer-term mortality following invasive pneumococcal disease
- (2016) G. J. HUGHES et al. EPIDEMIOLOGY AND INFECTION
- Burden and risk factors of ambulatory or hospitalized CAP: A population based cohort study
- (2016) Martin Kolditz et al. RESPIRATORY MEDICINE
- Rates of pneumonia among children and adults with chronic medical conditions in Germany
- (2015) Stephen I. Pelton et al. BMC INFECTIOUS DISEASES
- Long-term mortality of hospitalized pneumonia in the EPIC-Norfolk cohort
- (2015) P. K. MYINT et al. EPIDEMIOLOGY AND INFECTION
- Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
- (2015) Marie-Josée J. Mangen et al. EUROPEAN RESPIRATORY JOURNAL
- Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease
- (2015) Vicente F. Corrales-Medina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
- (2015) Marc J.M. Bonten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community
- (2015) Bernhard Ultsch et al. PHARMACOECONOMICS
- Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan
- (2015) Shu-ling Hoshi et al. PLoS One
- The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England
- (2012) Albert Jan van Hoek et al. JOURNAL OF INFECTION
- Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
- (2012) Elizabeth A. Clutterbuck et al. JOURNAL OF INFECTIOUS DISEASES
- Modeling Good Research Practices—Overview
- (2012) J. Jaime Caro et al. MEDICAL DECISION MAKING
- State-Transition Modeling
- (2012) Uwe Siebert et al. MEDICAL DECISION MAKING
- Model Parameter Estimation and Uncertainty Analysis
- (2012) Andrew H. Briggs et al. MEDICAL DECISION MAKING
- A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
- (2010) Neil French et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now